Ryan Specialty (NYSE:RYAN) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS

Ryan Specialty (NYSE:RYAN) posted its quarterly earnings results on Thursday. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.05), FiscalAI reports. The business had revenue of $751.21 million during the quarter, compared to the consensus estimate of $777.43 million. Ryan Specialty had a net margin of 7.61% and a return on equity of 47.93%.

Ryan Specialty Price Performance

NYSE RYAN traded up $1.33 during trading on Thursday, reaching $44.38. The company’s stock had a trading volume of 3,378,576 shares, compared to its average volume of 1,673,352. The firm has a fifty day moving average of $50.72 and a 200 day moving average of $54.27. Ryan Specialty has a one year low of $42.56 and a one year high of $77.16. The stock has a market capitalization of $11.71 billion, a PE ratio of 96.48, a P/E/G ratio of 1.13 and a beta of 0.62. The company has a debt-to-equity ratio of 2.72, a current ratio of 1.00 and a quick ratio of 1.00.

Analyst Ratings Changes

A number of equities research analysts have issued reports on RYAN shares. Keefe, Bruyette & Woods lowered their target price on shares of Ryan Specialty from $73.00 to $65.00 and set an “outperform” rating on the stock in a report on Monday, November 3rd. Jefferies Financial Group initiated coverage on Ryan Specialty in a research report on Monday, December 1st. They issued a “hold” rating and a $64.00 price target for the company. BMO Capital Markets dropped their price objective on Ryan Specialty from $70.00 to $66.00 and set an “outperform” rating on the stock in a report on Monday, November 3rd. Barclays reduced their target price on Ryan Specialty from $65.00 to $58.00 and set an “overweight” rating for the company in a report on Thursday, January 8th. Finally, The Goldman Sachs Group set a $61.00 price target on Ryan Specialty in a research report on Wednesday, January 7th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Ryan Specialty has a consensus rating of “Moderate Buy” and a consensus target price of $64.19.

Insider Activity at Ryan Specialty

In related news, CEO Timothy William Turner sold 129,570 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $53.61, for a total value of $6,946,247.70. Following the transaction, the chief executive officer directly owned 12,553 shares in the company, valued at approximately $672,966.33. This represents a 91.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 52.21% of the company’s stock.

Institutional Investors Weigh In On Ryan Specialty

Hedge funds have recently bought and sold shares of the stock. Royal Bank of Canada increased its holdings in shares of Ryan Specialty by 10.6% in the 1st quarter. Royal Bank of Canada now owns 59,639 shares of the company’s stock worth $4,406,000 after buying an additional 5,739 shares during the last quarter. AQR Capital Management LLC grew its position in Ryan Specialty by 25.1% in the first quarter. AQR Capital Management LLC now owns 4,972 shares of the company’s stock worth $367,000 after acquiring an additional 998 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Ryan Specialty by 46.3% in the first quarter. Goldman Sachs Group Inc. now owns 376,154 shares of the company’s stock valued at $27,787,000 after acquiring an additional 119,055 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Ryan Specialty by 11.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 332,823 shares of the company’s stock valued at $24,586,000 after purchasing an additional 33,667 shares in the last quarter. Finally, Creative Planning raised its position in Ryan Specialty by 15.4% during the second quarter. Creative Planning now owns 4,586 shares of the company’s stock valued at $312,000 after purchasing an additional 613 shares in the last quarter. 84.82% of the stock is currently owned by institutional investors.

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.